AustralianSuper Pty Ltd

Position in GILD — Gilead Sciences, Inc.

CIK 1694164 MELBOURNE, C3

Position in GILD

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$200,159,152

-$114,943,640 QoQ

Shares Held

1,436,171

-44.1% QoQ

Ownership

0.116%

of shares outstanding

% of Portfolio

1.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

AustralianSuper Pty Ltd holds $954,613,199 across 8 Drug Manufacturers - General names. GILD ranks #2 (21.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	276,856	$254,643,843
2	GILD	Gilead Sciences, Inc. This page	1,436,171	$200,159,152
3	PFE	Pfizer Inc	4,980,592	$139,855,023
4	BMY	Bristol Myers Squibb Co	2,125,356	$128,902,841
5	BIIB	Biogen Inc.	616,193	$112,966,662
6	MRK	Merck & Co., Inc.	575,397	$69,214,505
7	ABBV	AbbVie Inc.	204,149	$44,400,366
8	JNJ	Johnson & Johnson	18,290	$4,470,807

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$200,159,152	1,436,171	-44.1%	Shares	Sole	2026-05-07
2025-12-31	$315,102,792	2,567,238	-15.4%	Shares	Sole	2026-02-05
2025-09-30	$336,783,879	3,034,089	-10.2%	Shares	Sole	2025-11-12
2025-06-30	$374,524,957	3,378,055	+10.5%	Shares	Sole	2025-08-01
2025-03-31	$342,616,069	3,057,707	+168.6%	Shares	Sole	2025-05-05
2024-12-31	$105,141,907	1,138,269	+0.5%	Shares	Sole	2025-01-30
2024-09-30	$94,930,355	1,132,280	+11.4%	Shares	Sole	2024-10-28
2024-06-30	$69,754,826	1,016,686	+150.0%	Shares	Sole	2024-07-26
2024-03-31	$29,788,870	406,674	+75.6%	Shares	Sole	2024-04-26
2023-12-31	$18,756,893	231,538	+15.9%	Shares	Sole	2024-01-16
2023-09-30	$14,972,712	199,796	-4.3%	Shares	Sole	2023-10-27
2023-06-30	$16,096,069	208,850	+835.6%	Shares	Sole	2023-07-28
2023-03-31	$1,852,056	22,322	—	Shares	Sole	2023-04-21
No filing history on record for this holder in this stock.